PHS
ROIV icon

PFM Health Sciences’s Roivant Sciences ROIV Stock Holding History

PFM Health Sciences’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.75M Buy
+207,446
New +$5.33M 0.52% 58
2024
Q1 		– Sell
-1,215,033
Closed -$13.6M – 89
2023
Q4 		$13.6M Hold
1,215,033
– – 0.82% 41
2023
Q3 		$14.2M Buy
1,215,033
+830,042
+216% +$9.38M 0.67% 47
2023
Q2 		$3.88M Buy
+384,991
New +$3.44M 0.15% 70

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PFM Health Sciences's ROIV Position: Q1 2026 in Review

PFM Health Sciences opened a new position in Roivant Sciences (ROIV) in Q1 2026: 207,446 shares worth $5.75M. The stake represents 0.52% of the portfolio and ranks #58 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in ROIV as recently as Q4 2023.

PFM Health Sciences first reported a position in ROIV in Q2 2023 and has held it in 4 quarters since. The position peaked at $14.2M in Q3 2023. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • PFM Health Sciences held 207,446 shares of Roivant Sciences worth $5.75M as of Q1 2026.
  • Roivant Sciences was a new PFM Health Sciences position in Q1 2026.
  • Roivant Sciences made up 0.52% of PFM Health Sciences's portfolio in Q1 2026, its #58 holding.
  • PFM Health Sciences first reported a position in Roivant Sciences in Q2 2023 and has held it in 4 quarters since.
  • PFM Health Sciences's Roivant Sciences position peaked at $14.2M in Q3 2023.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.